Search Results
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Sarah J Delforce in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Eugenie R Lumbers in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Celine Corbisier de Meaultsart in
Google Scholar
PubMed
Search for other papers by Yu Wang in
Google Scholar
PubMed
Search for other papers by Anthony Proietto in
Google Scholar
PubMed
Search for other papers by Geoffrey Otton in
Google Scholar
PubMed
Search for other papers by Jim Scurry in
Google Scholar
PubMed
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Priority Research Centre for Cancer, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Nicole M Verrills in
Google Scholar
PubMed
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Ang I by angiotensin-converting enzyme (ACE), can act on the angiotensin II type 1 receptor (AGTR1) to stimulate angiogenesis and cell proliferation. There is also an additional RAS pathway that opposes the Ang II/AGTR1 pathway. This is the ACE2/Ang(1
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Sarah J Delforce in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Yu Wang in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Katie A Ashton in
Google Scholar
PubMed
Search for other papers by Anthony Proietto in
Google Scholar
PubMed
Search for other papers by Geoffrey Otton in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by C Caroline Blackwell in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Division of Molecular Medicine, Pathology North, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Eugenie R Lumbers in
Google Scholar
PubMed
the RAS which, via the angiotensin II type 1 receptor (AGTR1), stimulates angiogenesis and cell proliferation ( 4 , 5 , 6 ). In tissues, inactive prorenin is non-proteolytically activated by binding to the (pro)renin receptor (ATP6AP2), so it forms
Search for other papers by Wioletta Pijacka in
Google Scholar
PubMed
Search for other papers by Morag G Hunter in
Google Scholar
PubMed
Search for other papers by Fiona Broughton Pipkin in
Google Scholar
PubMed
Search for other papers by Martin R Luck in
Google Scholar
PubMed
Winther H Dantzer V Poulsen K . Dominance of type 1 angiotensin II receptor in the nonpregnant and pregnant bovine uterus . Journal of Reproduction and Fertility 1999 116 403 – 413 . ( doi:10.1530/jrf.0.1160403 ). 8 Wijayagunawardane MP
Search for other papers by M L M Barreto-Chaves in
Google Scholar
PubMed
Search for other papers by N Senger in
Google Scholar
PubMed
Search for other papers by M R Fevereiro in
Google Scholar
PubMed
Search for other papers by A C Parletta in
Google Scholar
PubMed
Search for other papers by A P C Takano in
Google Scholar
PubMed
-(1–9), angiotensin-(1–9); Ang-(1–7), angiotensin-(1–7); ACE, angiotensin I converting enzyme; ACE2, angiotensin II converting enzyme; AT1R, angiotensin II receptor type 1; AT2R, angiotensin II receptor type 2. Although the RAS has been
Search for other papers by Frans H H Leenen in
Google Scholar
PubMed
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
Search for other papers by Mordecai P Blaustein in
Google Scholar
PubMed
Search for other papers by John M Hamlyn in
Google Scholar
PubMed
White R Chen A Ahmad M Leenen FHH. Mineralocorticoid and angiotensin II type 1 receptors in the subfornical organ mediate angiotensin II: induced hypothalamic reactive oxygen species and hypertension . Neuroscience 2016 329 112
Search for other papers by Xue-Lian Zhang in
Google Scholar
PubMed
Search for other papers by Xinyi Zhao in
Google Scholar
PubMed
Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China
Search for other papers by Yong Wu in
Google Scholar
PubMed
Search for other papers by Wen-qing Huang in
Google Scholar
PubMed
Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China
Search for other papers by Jun-jiang Chen in
Google Scholar
PubMed
Search for other papers by Peijie Hu in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Yi-Wen Chen in
Google Scholar
PubMed
Search for other papers by Jin Hao in
Google Scholar
PubMed
Search for other papers by Rong-Rong Xie in
Google Scholar
PubMed
Search for other papers by Hsiao Chang Chan in
Google Scholar
PubMed
Search for other papers by Ye Chun Ruan in
Google Scholar
PubMed
Search for other papers by Hui Chen in
Google Scholar
PubMed
Search for other papers by Jinghui Guo in
Google Scholar
PubMed
( 3 ). RAS exerts its role through two arms with opposing functions. The pressor arm consists of renin, angiotensin-converting enzyme (ACE), angiotensin 2 and angiotensin type 1 receptor, which causes vasoconstriction. The other depressor arm consists
Search for other papers by Janaína Felix Braga in
Google Scholar
PubMed
Search for other papers by Daniela Ravizzoni Dartora in
Google Scholar
PubMed
Search for other papers by Natalia Alenina in
Google Scholar
PubMed
Search for other papers by Michael Bader in
Google Scholar
PubMed
Cardiology Institute of Rio Grande do Sul/University Foundation of Cardiology (IC/FUC), Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Robson Augusto Souza Santos in
Google Scholar
PubMed
. Alterations in gene expression in the testis of angiotensin-(1-7)-receptor Mas-deficient mice . Regulatory Peptides 2007 138 51 – 55 . ( doi:10.1016/j.regpep.2006.11.017 ) 7 Lazaroni TL Raslan AC Fontes WR de Oliveira ML Bader M Alenina N Moraes MF
Search for other papers by Peter L Kristensen in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Lægerne på Ellemarksvej, Køge, Denmark
Search for other papers by Rikke Due-Andersen in
Google Scholar
PubMed
Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark
Search for other papers by Thomas Høi-Hansen in
Google Scholar
PubMed
Novo Nordisk A/S, Søborg, Denmark
Search for other papers by Lise Grimmeshave in
Google Scholar
PubMed
Lund University Diabetes Centre, Skåne University Hospital, Malmø, Sweden
Search for other papers by Valeriya Lyssenko in
Google Scholar
PubMed
Finnish Institute for Molecular Medicine (FIMM), Helsinki University, Helsinki, Finland
Search for other papers by Leif Groop in
Google Scholar
PubMed
Department of Biomedical Sciences, NNF Center for Basic Metabolic Research, The Panum Institute, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Department of Endocrinology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
Search for other papers by Allan A Vaag in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birger Thorsteinsson in
Google Scholar
PubMed
hypoglycaemia is largely unexplained. We previously speculated whether genetic factors are implicated and reported a high rate of severe hypoglycaemia in type 1 diabetic subjects carrying the common deletion-allele of the angiotensin-converting enzyme (ACE) gene
Search for other papers by Dmitry M Davydov in
Google Scholar
PubMed
Search for other papers by Malik K Nurbekov in
Google Scholar
PubMed
levels were higher in D allele carriers of ACE ( DD & ID genotypes) compared with subjects with II genotype ( Table 4 ). Table 4 Main effects of polymorphisms of the dopamine D2 receptor ( DRD2/ANKK1 ), angiotensin 1 converting enzyme
Search for other papers by Martin Wiegand in
Google Scholar
PubMed
Search for other papers by David J Halsall in
Google Scholar
PubMed
Search for other papers by Sarah L Cowan in
Google Scholar
PubMed
Search for other papers by Kevin Taylor in
Google Scholar
PubMed
Search for other papers by Robert J B Goudie in
Google Scholar
PubMed
Search for other papers by Jacobus Preller in
Google Scholar
PubMed
Wellcome–MRC Institute of Metabolic Science, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
activation by converting angiotensin II (AngII) to angiotensin 1–7 (Ang 1–7). Ang 1–7 exerts anti-inflammatory, anti-oxidative and vasodilatory effects via binding to the Mas receptor ( 4 ). AngII binds AngII receptor type 1 which then exerts pro